Press Release / 20 April 2020
Today, the European Commission together with several partners launched a European COVID-19 Data Platform to enable the rapid collection and sharing of available research data.
Life Sciences is one of the sectors most dynamic in the global scientific landscape, It characterized by a strong inter- and transversality. It is a sector in which the Italian industry has a high specialization and competitiveness: develops 43 billion euro turnover that 23 to foreign markets.
The region of Calabria has indicated Life Sciences one of the seven priority areas for innovation for its Smart Specialization Strategy (S3), The strategy document for research and innovation for the programming period of the European Structural and Investment Funds 2014-2020, consistent with the Europe 2020 Strategy.
Regionally , indeed, Life Sciences is a well established research area, interconnected to external networks as well as regional health care. its 35 departments and regional research centers, the Life Sciences area is in first place for number of employees researchers (328, of which 225 role) and financing intercepted (quasi40 M€ in 4 years). The consistency of this research offer is determined by the presence in Calabria of institutes and departments devoted entirely, but also by various research groups in other areas: the University Magna Graecia, the University of Calabria and the CNR.
The analysis of the international scenario, The trends identified in S3 from the Calabria Region and the areas of specialization of member companies in Biotecnomed, They have guided the choice of research trajectories and development efforts on issues that enhance the search for strong impact on the market and on public health: the regenerative medicine, the advanced diagnostics, the nutraceutica, the neuromotor rehabilitation.
